Global Antisense and RNAi Therapeutics market survey available in new report

0
121
Want create site? Find Free WordPress Themes and plugins.

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene “off”.

Scope of the Report:
This report studies the Antisense & RNAi Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antisense & RNAi Therapeutics market by product type and applications/end industries.
North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.
The global Antisense & RNAi Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antisense & RNAi Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Get a FREE sample Copy of this report : https://www.1marketresearch.com/market-reports/antisense-and-rnai-therapeutics-market-industry-report-71632#tab-request_sample

Market Segment by Manufacturers, this report covers

Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.

Browse Report :https://www.1marketresearch.com/market-reports/antisense-and-rnai-therapeutics-market-industry-report-71632

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
RNA interference
SiRNA
MiRNA
Antisense RNA

Market Segment by Applications, can be divided into
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
About Us:

1MarketResearch.com is a global business market research providing syndicated research Report, customized research reports, company profiles and industry databases across multiple domains.
We provide intellectual, precise and meaningful data at a lightning speed.
We host more than 500,000 Industry research products.

Contact US:

1MarketResearch.com
304, S. Jones Blvd, #3299,
Las Vegas, NV – 89107
USA : +1 702-425-8599
Email : Sales@1MarketResearch.com
Web : https://www.1MarketResearch.com

Did you find apk for android? You can find new Free Android Games and apps.